Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5040596 | 0.91 | ALDH1A1 (0.34) | ALDH1A1TSHRMAPK1SIGMAR1 | |
| SCHEMBL4914946 | 0.91 | ALDH1A1 (0.34) | ALDH1A1TSHRMAPK1SIGMAR1 | |
| SCHEMBL4742297 | 0.91 | ALDH1A1 (0.34) | ALDH1A1TSHRMAPK1SIGMAR1 | |
| SCHEMBL18782746 | 0.85 | SIGMAR1 (0.48) | ALDH1A1TSHRMAPK1SIGMAR1HTR2A | |
| SCHEMBL12039786 | 0.85 | ANPEP (0.36) | ALDH1A1TSHRMAPK1SIGMAR1ADRB2 | |
| SCHEMBL3755293 | 0.85 | SIGMAR1 (0.42) | ALDH1A1SIGMAR1 | |
| SCHEMBL4788706 | 0.85 | SIGMAR1 (0.42) | ALDH1A1SIGMAR1 | |
| SCHEMBL13995821 | 0.85 | ANPEP (0.36) | ALDH1A1TSHRMAPK1SIGMAR1ADRB2 | |
| SCHEMBL7967478 | 0.83 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL4917726 | 0.83 | ALDH1A1 (0.35) | ALDH1A1TSHRMAPK1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1914254-B1 | Crosslinkers for improving stability of polyurethane foams | EVONIK DEGUSSA GMBH (DE) | 2017-08-23 | — | — | EP | claimed |
| EP-2840164-A1 | Compositions and methods using same for flowable oxide deposition | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-02-25 | — | — | EP | claimed |
| EP-1914254-A1 | Crosslinkers for improving stability of polyurethane foams | Air Products and Chemicals, Inc. (US) | 2008-04-23 | — | — | EP | claimed |
| US-20080090922-A1 | Crosslinkers for improving stability of polyurethane foams | EVONIK OPERATIONS GMBH (DE) | 2008-04-17 | — | — | US | claimed |
| EP-4407067-A1 | PLATING BATH COMPOSITION FOR PLATING OF PRECIOUS METAL AND A METHOD FOR DEPOSITING A PRECIOUS METAL LAYER | Atotech Deutschland GmbH & Co. KG (DE) | 2024-07-31 | — | — | EP | disclosed |
| EP-3390483-B1 | ENCAPSULATION | PROCTER & GAMBLE (US) | 2022-05-18 | — | — | EP | disclosed |
| EP-3368207-B1 | ENCAPSULATION | ENCAPSYS LLC (US) | 2021-12-01 | — | — | EP | disclosed |
| US-10864167-B2 | Encapsulation | THE PROCTER & GAMBLE COMPANY (US) | 2020-12-15 | — | — | US | disclosed |
| US-10170297-B2 | Compositions and methods using same for flowable oxide deposition | VERSUM MATERIALS US, LLC (US) | 2019-01-01 | — | — | US | disclosed |
| US-20180235893-A1 | ENCAPSULATION | THE PROCTER & GAMBLE COMPANY | 2018-08-23 | — | — | US | disclosed |
| US-9937477-B2 | Encapsulation | WATERTITE PRODUCTS, INC. | 2018-04-10 | — | — | US | disclosed |
| EP-1914254-B1 | Crosslinkers for improving stability of polyurethane foams | EVONIK DEGUSSA GMBH (DE) | 2017-08-23 | — | — | EP | disclosed |
| US-20050161644-A1 | carrier medium and at least one additive such as alkyl polyglycoside, alkyl alcohol, or various ethylene oxide adducts; use at an operating wavelength ranging from 140 nm to 248 nm, and a refractive index greater than water at an operating wavelength | AIR PRODUCTS AND CHEMICALS, INC. | 2005-07-28 | — | — | US | disclosed |
| EP-1557721-A2 | Immersion lithography fluids | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2005-07-27 | — | — | EP | disclosed |
| EP-1530232-A2 | Process solutions containing surfactants used as post-chemical mechanical planarization treatment | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2005-05-11 | — | — | EP | disclosed |
| US-20050081885-A1 | Process solutions containing surfactants used as post-chemical mechanical planarization treatment | VERSUM MATERIALS US, LLC | 2005-04-21 | — | — | US | disclosed |
| US-20040204328-A1 | Process solutions containing surfactants | AZ ELECTRONIC MATERIALS S.À R.L. (LU) | 2004-10-14 | — | — | US | disclosed |
| US-20040053800-A1 | Process solutions containing surfactants | AZ ELECTRONIC MATERIALS S.À R.L. (LU) | 2004-03-18 | — | — | US | disclosed |
| EP-1389746-A2 | Process solutions containing surfactants | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2004-02-18 | — | — | EP | disclosed |
| US-20040029396-A1 | Process solutions containing surfactants | VERSUM MATERIALS US, LLC | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180235893-A1 | ENCAPSULATION | ACR, ACMSD, SAMM50 | ALDH1A1 592/4885TSHR 4720/4885MAPK1 2990/4885 |
| US-10864167-B2 | Encapsulation | ACR, MPHOSPH6, ACMSD | ALDH1A1 810/4885TSHR 4661/4885MAPK1 2828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.